Prosecution Insights
Last updated: July 17, 2026
Application No. 17/997,743

METHOD FOR PREPARING A COMPOSITION COMPRISING AT LEAST THE MIXTURE OF AT LEAST ONE PEROXYDICARBONATE AND AT LEAST ONE PEROXYESTER

Final Rejection §103
Filed
Mar 07, 2023
Priority
May 20, 2020 — FR FR2005309 +1 more
Examiner
BRANCH, CATHERINE S
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Arkema France
OA Round
2 (Final)
86%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
817 granted / 955 resolved
+20.5% vs TC avg
Minimal +3% lift
Without
With
+3.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
14 currently pending
Career history
977
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
58.0%
+18.0% vs TC avg
§102
10.0%
-30.0% vs TC avg
§112
21.9%
-18.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 955 resolved cases

Office Action

§103
DETAILED ACTION This communication responds to the Amendment filed January 28, 2026. Claims 20-38 are currently pending. Claims 20-36 and 38 are under examination. The objection to claim 22 set forth in the Office Action dated October 1, 2025 is WITHDRAWN due to Applicant’s responsive amendment. The rejections of claims 20-36 under 35 USC 112 set forth in the October 1 Office Action are WITHDRAWN due to Applicant’s responsive amendments. The rejections of claims 20-36 under 35 USC 102 or 103 set forth in the October 1 Office Action are WITHDRAWN due to Applicant’s amendments. The examiner agrees with Applicant that the relied-upon prior art reference does not explicitly disclose water in the amount of 50 to 90 weight percent. Claims 20-36 are newly REJECTED for the reasons set forth below. New claim 38 is also rejected. The new rejections are necessitated by amendment. Therefore, this action is final. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 20-36 and 38 are rejected under 35 U.S.C. 103 as being unpatentable over Iwasaki et al. (JP H07252308A). Regarding claims 20, 25-30, 35, and 36, Iwasaki teaches a process for forming a composition of organic peroxides comprising diluting 3-hydroxy-1,1-dimethylbutylperoxyneodecanoate and one or more peroxydicarbonates in water. (paras. [0005], [0010]; para. [0019], Table 1.) The peroxide mixture is then contacted with vinyl chloride monomer. (Exs., para. [0014].) As Applicant points out in its Remarks, Iwasaki’s only disclosure as to the amount of water present in its composition is in its Examples, and that the water is present in amounts greater than 50 to 90 wt.%. (See Remarks, pp. 7-8.) However, differences in concentration will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration is critical. (MPEP 2144.05(II)(A).) "[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." (In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955) (Claimed process which was performed at a temperature between 40°C and 80°C and an acid concentration between 25% and 70% was held to be prima facie obvious over a reference process which differed from the claims only in that the reference process was performed at a temperature of 100°C and an acid concentration of 10%.); see also Peterson, 315 F.3d at 1330, 65 USPQ2d at 1382 ("The normal desire of scientists or artisans to improve upon what is already generally known provides the motivation to determine where in a disclosed set of percentage ranges is the optimum combination of percentages."); In re Hoeschele, 406 F.2d 1403, 160 USPQ 809 (CCPA 1969) (Claimed elastomeric polyurethanes which fell within the broad scope of the references were held to be unpatentable thereover because, among other reasons, there was no evidence of the criticality of the claimed ranges of molecular weight or molar proportions.).) In this case, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have optimized through routine experimentation the relative amount of water to produce a composition with the desired stability and concentration of polymerization initiators. Regarding claims 21-24, Iwasaki teaches that a preferred peroxydicarbonate is di-2-ethylhexyl-peroxydicarbonate. (para. [0018]; para. [0019], Table 1.) Regarding claims 31 and 32, Iwasaki teaches the addition of polyvinyl alcohol (an emulsifier) to the aqueous peroxide mixture (see Exs., para. [0014]), thereby forming an aqueous emulsion. Regarding claim 33, Iwasaki is silent as to the temperature of preparing the peroxide mixture. A person of ordinary skill would infer that the temperature is room temperature, or ~20°C, absent any teaching otherwise. Regarding claim 34, Iwasaki teaches all of the limitations of claim 20. (See paragraph 10 above, which is incorporated by reference herein.) The difference between Iwasaki and claim 34 is that Iwasaki teaches that the peroxide mixture is added to the reactor, then the monomer is added, rather than the recited process in which the peroxide is added to a reactor already containing monomer. However, the selection of any order of performing process steps is prima facie obvious in the absence of new or unexpected results. (In re Burhans, 154 F.2d 690, 69 USPQ 330 (CCPA 1946); In re Gibson, 39 F.2d 975, 5 USPQ 230 (CCPA 1930) (selection of any order of mixing ingredients is prima facie obvious.).) Thus, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have performed the process steps of Iwasaki in the order recited in claim 34. Regarding claim 38, Iwasaki teaches a general ratio of peroxyester to peroxydicarbonate of 5/1 to 1/5, which overlaps the claimed range. In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. (In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).) It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have selected the overlapping portion of the range taught by Iwasaki. Response to Arguments Applicant’s arguments with respect to the rejections of claims 20-36 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, new rejections are set forth above. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CATHERINE S BRANCH whose telephone number is (571)270-3539. The examiner can normally be reached Monday through Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at 571-272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. CATHERINE S. BRANCH Primary Examiner Art Unit 1763 /CATHERINE S BRANCH/Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Mar 07, 2023
Application Filed
Oct 01, 2025
Non-Final Rejection mailed — §103
Jan 28, 2026
Response Filed
May 29, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679908
CATALYST SYSTEMS AND PROCESSES FOR PRODUCING POLYETHYLENE USING THE SAME
3y 7m to grant Granted Jul 14, 2026
Patent 12662560
Polyethylene Composition and Method for Preparing the Same
4y 1m to grant Granted Jun 23, 2026
Patent 12662562
METHOD FOR MANUFACTURING LOW-MOLECULAR-WEIGHT POLYTETRAFLUOROETHYLENE
4y 0m to grant Granted Jun 23, 2026
Patent 12662554
MULTISTAGE PROCESS FOR PRODUCING POLYMER DISPERSION OF DISCRETE PARTICLES
3y 3m to grant Granted Jun 23, 2026
Patent 12665247
COPOLYMER, INJECTION MOLDED BODY, MEMBER TO BE COMPRESSED, AND COATED ELECTRICAL WIRE
3y 2m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
86%
Grant Probability
89%
With Interview (+3.4%)
2y 4m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 955 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month